IRVINE, Calif., Sept. 22, 2023 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer, will present a company overview on Tuesday, October 3, 2023…Read More
ReShape Lifesciences Announces Participation in the LD Micro Main Event XVI
